Antidiabetic Effect of Bifidobacterium animalis TISTR 2591 in a Rat Model of Type 2 Diabetes.
Bifidobacterium animalis
Diabetes
Inflammatory cytokines
Liver fat accumulation
Oxidative stress
Journal
Probiotics and antimicrobial proteins
ISSN: 1867-1314
Titre abrégé: Probiotics Antimicrob Proteins
Pays: United States
ID NLM: 101484100
Informations de publication
Date de publication:
09 Oct 2024
09 Oct 2024
Historique:
accepted:
02
10
2024
medline:
10
10
2024
pubmed:
10
10
2024
entrez:
9
10
2024
Statut:
aheadofprint
Résumé
This study investigated the beneficial effects of probiotic Bifidobacterium animalis TISTR 2591 on the regulation of blood glucose and its possible mechanisms in a rat model of type 2 diabetes. The type 2 diabetic-Sprague Dawley rats were established by the combination of a high-fat diet and a low dose of streptozotocin. After 4 weeks of treatment with 2 × 10
Identifiants
pubmed: 39384734
doi: 10.1007/s12602-024-10377-2
pii: 10.1007/s12602-024-10377-2
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Références
Sun H, Saeedi P, Karuranga S, et al (2022) IDF Diabetes Atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract 183. https://doi.org/10.1016/j.diabres.2021.109119
Galicia-Garcia U, Benito-Vicente A, Jebari S et al (2020) Pathophysiology of type 2 diabetes mellitus. Int J Mol Sci 21:6275
doi: 10.3390/ijms21176275
Prasad M, Rajagopal P, Devarajan N et al (2022) A comprehensive review on high-fat diet-induced diabetes mellitus: an epigenetic view. J Nutr Biochem 107:109037. https://doi.org/10.1016/j.jnutbio.2022.109037
doi: 10.1016/j.jnutbio.2022.109037
Yaribeygi H, Sathyapalan T, Atkin SL, Sahebkar A (2020) Molecular mechanisms linking oxidative stress and diabetes mellitus. Oxid Med Cell Longev 2020:1–13. https://doi.org/10.1155/2020/8609213
doi: 10.1155/2020/8609213
James DE, Stöckli J, Birnbaum MJ (2021) The aetiology and molecular landscape of insulin resistance. Nat Rev Mol Cell Biol 22:751–771. https://doi.org/10.1038/s41580-021-00390-6
doi: 10.1038/s41580-021-00390-6
Ziolkowska S, Binienda A, Jabłkowski M et al (2021) The interplay between insulin resistance, inflammation, oxidative stress, base excision repair and metabolic syndrome in nonalcoholic fatty liver disease. Int J Mol Sci 22:11128. https://doi.org/10.3390/ijms222011128
doi: 10.3390/ijms222011128
Salles BIM, Cioffi D, Ferreira SRG (2020) Probiotics supplementation and insulin resistance: a systematic review. Diabetol Metab Syndr 12. https://doi.org/10.1186/s13098-020-00603-6
Wang G, Liu J, Xia Y, Ai L (2021) Probiotics-based interventions for diabetes mellitus: a review. Food Biosci 43:101172
doi: 10.1016/j.fbio.2021.101172
Zhou Z, Sun B, Yu D, Zhu C (2022) Gut microbiota: an important player in type 2 diabetes mellitus. Front Cell Infect Microbiol 12. https://doi.org/10.3389/fcimb.2022.834485
Gurung M, Li Z, You H et al (2020) Role of gut microbiota in type 2 diabetes pathophysiology. EBioMedicine 51:102590. https://doi.org/10.1016/j.ebiom.2019.11.051
doi: 10.1016/j.ebiom.2019.11.051
Gao K, Ren X, Chen C et al (2023) Oral administration of Bifidobacterium longum WHH2270 ameliorates type 2 diabetes in rats. J Food Sci 88:3967–3983. https://doi.org/10.1111/1750-3841.16727
doi: 10.1111/1750-3841.16727
Ben Othman M, Sakamoto K (2020) Effect of inactivated Bifidobacterium longum intake on obese diabetes model mice (TSOD). Food Research International 129. https://doi.org/10.1016/j.foodres.2019.108792
Qian X, Si Q, Lin G, et al (2022) Bifidobacterium adolescentis is effective in relieving type 2 diabetes and may be related to its dominant core genome and gut microbiota modulation capacity. Nutrients 14. https://doi.org/10.3390/nu14122479
Soleimani A, Motamedzadeh A, Zarrati Mojarrad M et al (2019) The effects of synbiotic supplementation on metabolic status in diabetic patients undergoing hemodialysis: a randomized, double-blinded, placebo-controlled trial. Probiotics Antimicrob Proteins 11:1248–1256. https://doi.org/10.1007/s12602-018-9499-3
doi: 10.1007/s12602-018-9499-3
Wongmanee N, Rojanaverawong W, Boonsong T, Hanchang W (2024) Antihyperglycemic effect of extra virgin sacha inchi oil in type 2 diabetic rats: mechanisms involved in pancreatic β-cell function and apoptosis. J Tradit Complement Med 14:148–161. https://doi.org/10.1016/j.jtcme.2023.08.005
doi: 10.1016/j.jtcme.2023.08.005
Akel Bilgic H, Kilic B, Kockaya BD et al (2023) Oxidative stress stimulation leads to cell-specific oxidant and antioxidant responses in airway resident and inflammatory cells. Life Sci 315:121358. https://doi.org/10.1016/j.lfs.2022.121358
doi: 10.1016/j.lfs.2022.121358
Yoopum S, Wongmanee N, Rojanaverawong W et al (2023) Mango (Mangifera indica L.) seed kernel extract suppresses hyperglycemia by modulating pancreatic β cell apoptosis and dysfunction and hepatic glucose metabolism in diabetic rats. Environ Sci Pollut Res 30:123286–123308. https://doi.org/10.1007/s11356-023-31066-7
doi: 10.1007/s11356-023-31066-7
Jin Z, Zhang W, Luo Y et al (2021) Protective effect of Qingre Huoxue decoction against myocardial infarction via PI3K/Akt autophagy pathway based on UPLC-MS, network pharmacology, and in vivo evidence. Pharm Biol 59:1605–1616. https://doi.org/10.1080/13880209.2021.2001542
doi: 10.1080/13880209.2021.2001542
Rojanaverawong W, Wongmanee N, Hanchang W (2023) Sacha Inchi (Plukenetia volubilis L.) Oil improves hepatic insulin sensitivity and glucose metabolism through insulin signaling pathway in a rat model of type 2 diabetes. Prev Nutr Food Sci 28. https://doi.org/10.3746/pnf.2023.28.1.30
Sun X-W, Li H-R, Jin X-L et al (2024) Structural and functional differences in small intestinal and fecal microbiota: 16S rRNA gene investigation in rats. Microorganisms 12:1764. https://doi.org/10.3390/microorganisms12091764
doi: 10.3390/microorganisms12091764
Yang J, Chun J (2021) Taxonomic composition and variation in the gut microbiota of laboratory mice. Mamm Genome 32:297–310. https://doi.org/10.1007/s00335-021-09871-7
doi: 10.1007/s00335-021-09871-7
Wang N, Gao X, Zhang Z, Yang L (2022) Composition of the gut microbiota in attention deficit hyperactivity disorder: a systematic review and meta-analysis. Front Endocrinol (Lausanne) 13. https://doi.org/10.3389/fendo.2022.838941
Jost L (2010) The relation between evenness and diversity. Diversity (Basel) 2:207–232. https://doi.org/10.3390/d2020207
doi: 10.3390/d2020207
Armstrong G, Cantrell K, Huang S et al (2021) Efficient computation of Faith’s phylogenetic diversity with applications in characterizing microbiomes. Genome Res 31:2131–2137. https://doi.org/10.1101/gr.275777.121
doi: 10.1101/gr.275777.121
Zikou E, Dovrolis N, Dimosthenopoulos C et al (2023) The effect of probiotic supplements on metabolic parameters of people with type 2 diabetes in greece—a randomized, double-blind, placebo-controlled study. Nutrients 15:4663. https://doi.org/10.3390/nu15214663
doi: 10.3390/nu15214663
Wickramasinghe ASD, Attanayake AP, Kalansuriya P (2022) Biochemical characterization of high fat diet fed and low dose streptozotocin induced diabetic Wistar rat model. J Pharmacol Toxicol Methods 113:107144. https://doi.org/10.1016/j.vascn.2021.107144
doi: 10.1016/j.vascn.2021.107144
Zhang C, Fang B, Zhang N et al (2024) The effect of Bifidobacterium animalis subsp. lactis MN-gup on glucose metabolism, gut microbiota, and their metabolites in type 2 diabetic mice. Nutrients 16:1691. https://doi.org/10.3390/nu16111691
doi: 10.3390/nu16111691
Zhang J, Wang S, Zeng Z et al (2020) Anti-diabetic effects of Bifidobacterium animalis 01 through improving hepatic insulin sensitivity in type 2 diabetic rat model. J Funct Foods 67:103843. https://doi.org/10.1016/j.jff.2020.103843
doi: 10.1016/j.jff.2020.103843
Jiang T, Li Y, Li L et al (2022) Bifidobacterium longum 070103 fermented milk improve glucose and lipid metabolism disorders by regulating gut microbiota in mice. Nutrients 14:4050. https://doi.org/10.3390/nu14194050
doi: 10.3390/nu14194050
Slouha E, Rezazadah A, Farahbod K et al (2023) Type-2 diabetes mellitus and the gut microbiota: systematic review. Cureus. https://doi.org/10.7759/cureus.49740
doi: 10.7759/cureus.49740
Markowiak-Kopeć P, Śliżewska K (2020) The effect of probiotics on the production of short-chain fatty acids by human intestinal microbiome. Nutrients 12:1107
doi: 10.3390/nu12041107
Dunseath GJ, Luzio SD, Peter R, Owens DR (2022) The pathophysiology of glucose intolerance in newly diagnosed, untreated T2DM. Acta Diabetol 59. https://doi.org/10.1007/s00592-021-01785-9
Sanches JM, Zhao LN, Salehi A et al (2023) Pathophysiology of type 2 diabetes and the impact of altered metabolic interorgan crosstalk. FEBS J 290:620–648. https://doi.org/10.1111/febs.16306
doi: 10.1111/febs.16306
Du XX, Tao X, Liang S, et al (2019) Hypoglycemic effect of acidic polysaccharide from Schisandra chinensis on T2D rats induced by high-fat diet combined with STZ. Biol Pharm Bull 42. https://doi.org/10.1248/bpb.b18-00915
Hanchang W, Khamchan A, Wongmanee N, Seedadee C (2019) Hesperidin ameliorates pancreatic β-cell dysfunction and apoptosis in streptozotocin-induced diabetic rat model. Life Sci 235. https://doi.org/10.1016/j.lfs.2019.116858
Wang Y, Dilidaxi D, Wu Y, et al (2020) Composite probiotics alleviate type 2 diabetes by regulating intestinal microbiota and inducing GLP-1 secretion in db/db mice. Biomedicine and Pharmacotherapy 125. https://doi.org/10.1016/j.biopha.2020.109914
Zeng Z, Yuan Q, Yu R, et al (2019) Ameliorative effects of probiotic Lactobacillus paracasei NL41 on insulin sensitivity, oxidative stress, and beta-cell function in a type 2 diabetes mellitus rat model. Mol Nutr Food Res 63. https://doi.org/10.1002/mnfr.201900457
Santoleri D, Titchenell PM (2019) Resolving the paradox of hepatic insulin resistance. CMGH 7:447
Jiang S, Young JL, Wang K et al (2020) Diabetic-induced alterations in hepatic glucose and lipid metabolism: the role of type 1 and type 2 diabetes mellitus (Review). Mol Med Rep 22:603
doi: 10.3892/mmr.2020.11175
Li H, Xu Q, Xu C, et al (2021) Bicyclol regulates hepatic gluconeogenesis in rats with type 2 diabetes and non-alcoholic fatty liver disease by inhibiting inflammation. Front Pharmacol 12. https://doi.org/10.3389/fphar.2021.644129
Kim G, Yoon Y, Park JH et al (2022) Bifidobacterial carbohydrate/nucleoside metabolism enhances oxidative phosphorylation in white adipose tissue to protect against diet-induced obesity. Microbiome 10:188. https://doi.org/10.1186/s40168-022-01374-0
doi: 10.1186/s40168-022-01374-0
Uehara K, Santoleri D, Whitlock AEG, Titchenell PM (2023) Insulin regulation of hepatic lipid homeostasis. In: Comprehensive Physiology. Wiley, 4785–4809. https://doi.org/10.1002/cphy.c220015
Fujii H, Kawada N (2020) The role of insulin resistance and diabetes in nonalcoholic fatty liver disease. Int J Mol Sci 21:3863. https://doi.org/10.3390/ijms21113863
doi: 10.3390/ijms21113863
Al-Harbi LN, Alshammari GM, Al-Dossari AM et al (2021) Beta vulgaris L. (Beetroot) methanolic extract prevents hepatic steatosis and liver damage in T2DM rats by hypoglycemic, insulin-sensitizing, antioxidant effects, and upregulation of PPARα. Biology (Basel) 10:1306. https://doi.org/10.3390/biology10121306
doi: 10.3390/biology10121306
Smith GI, Shankaran M, Yoshino M et al (2020) Insulin resistance drives hepatic de novo lipogenesis in nonalcoholic fatty liver disease. J Clin Investig 130:1453–1460. https://doi.org/10.1172/JCI134165
doi: 10.1172/JCI134165
Do MH, Oh MJ, Lee H Bin, et al (2022) Bifidobacterium animalis ssp. lactis MG741 reduces body weight and ameliorates nonalcoholic fatty liver disease via improving the gut permeability and amelioration of inflammatory cytokines. Nutrients 14. https://doi.org/10.3390/nu14091965
Yan Y, Liu C, Zhao S, et al (2020) Probiotic Bifidobacterium lactis V9 attenuates hepatic steatosis and inflammation in rats with non-alcoholic fatty liver disease. AMB Express 10. https://doi.org/10.1186/s13568-020-01038-y
Lu Y, Zhang C, Song Y et al (2023) Gallic acid impairs fructose-driven de novo lipogenesis and ameliorates hepatic steatosis via AMPK-dependent suppression of SREBP-1/ACC/FASN cascade. Eur J Pharmacol 940:175457. https://doi.org/10.1016/j.ejphar.2022.175457
doi: 10.1016/j.ejphar.2022.175457
Khadke SP, Kuvalekar AA, Harsulkar AM, Mantri N (2019) High energy intake induced overexpression of transcription factors and its regulatory genes involved in acceleration of hepatic lipogenesis: a rat model for type 2 diabetes. Biomedicines 7. https://doi.org/10.3390/biomedicines7040076
Song DF, Yin L, Wang C, Wen XY (2019) Adenovirus-mediated expression of SIK1 improves hepatic glucose and lipid metabolism in type 2 diabetes mellitus rats. PLoS One 14. https://doi.org/10.1371/journal.pone.0210930
Lytrivi M, Castell AL, Poitout V, Cnop M (2020) Recent insights into mechanisms of β-cell lipo- and glucolipotoxicity in type 2 diabetes. J Mol Biol 432:1514
doi: 10.1016/j.jmb.2019.09.016
Rohm TV, Meier DT, Olefsky JM, Donath MY (2022) Inflammation in obesity, diabetes, and related disorders. Immunity 55:31–55. https://doi.org/10.1016/j.immuni.2021.12.013
doi: 10.1016/j.immuni.2021.12.013
Luc K, Schramm-Luc A, Guzik TJ, Mikolajczyk TP (2019) Oxidative stress and inflammatory markers in prediabetes and diabetes. J Physiol Pharmacol 70. https://doi.org/10.26402/jpp.2019.6.01
Oguntibeju OO (2019) Type 2 diabetes mellitus, oxidative stress and inflammation: examining the links. Int J Physiol Pathophysiol Pharmacol 11:45
Wronka M, Krzemińska J, Młynarska E et al (2022) The influence of lifestyle and treatment on oxidative stress and inflammation in diabetes. Int J Mol Sci 23:15743. https://doi.org/10.3390/ijms232415743
doi: 10.3390/ijms232415743
Liu S, Yu J, Fu M, et al (2021) Regulatory effects of hawthorn polyphenols on hyperglycemic, inflammatory, insulin resistance responses, and alleviation of aortic injury in type 2 diabetic rats. Food Research International 142. https://doi.org/10.1016/j.foodres.2021.110239
Mu J, Xin G, Zhang B et al (2020) Beneficial effects of Aronia melanocarpa berry extract on hepatic insulin resistance in type 2 diabetes mellitus rats. J Food Sci 85:1307–1318. https://doi.org/10.1111/1750-3841.15109
doi: 10.1111/1750-3841.15109
Wang N, Wang S, Xu B, et al (2021) Alleviation effects of Bifidobacterium animalis subsp. lactis XLTG11 on dextran sulfate sodium-induced colitis in mice. Microorganisms 9. https://doi.org/10.3390/microorganisms9102093
Ma L, Zheng A, Ni L, et al (2022) Bifidobacterium animalis subsp. lactis lkm512 attenuates obesity‐associated inflammation and insulin resistance through the modification of gut microbiota in high‐fat diet‐induced obese mice. Mol Nutr Food Res 66. https://doi.org/10.1002/mnfr.202100639
Zhang P, Li T, Wu X et al (2020) Oxidative stress and diabetes: antioxidative strategies. Front Med 14:583
doi: 10.1007/s11684-019-0729-1
Darenskaya MA, Kolesnikova LI, Kolesnikov SI (2021) Oxidative stress: pathogenetic role in diabetes mellitus and its complications and therapeutic approaches to correction. Bull Exp Biol Med 171:179–189. https://doi.org/10.1007/s10517-021-05191-7
doi: 10.1007/s10517-021-05191-7
Zhao D, Yin D, Wang X et al (2023) Taurine alleviates high-fat-high-glucose-induced pancreatic islet β-cell oxidative stress and apoptosis in rat. Heliyon 9:e21879. https://doi.org/10.1016/j.heliyon.2023.e21879
doi: 10.1016/j.heliyon.2023.e21879
Singh A, Kukreti R, Saso L, Kukreti S (2022) Mechanistic insight into oxidative stress-triggered signaling pathways and type 2 diabetes. Molecules 27:950. https://doi.org/10.3390/molecules27030950
doi: 10.3390/molecules27030950
Salazar-García M, Corona JC (2021) The use of natural compounds as a strategy to counteract oxidative stress in animal models of diabetes mellitus. Int J Mol Sci 22:7009
doi: 10.3390/ijms22137009
Alruhaimi RS, Mostafa-Hedeab G, Abduh MS, et al (2023) A flavonoid-rich fraction of Euphorbia peplus attenuates hyperglycemia, insulin resistance, and oxidative stress in a type 2 diabetes rat model. Front Pharmacol 14. https://doi.org/10.3389/fphar.2023.1204641
Naseri K, Saadati S, Ghaemi F et al (2022) The effects of probiotic and synbiotic supplementation on inflammation, oxidative stress, and circulating adiponectin and leptin concentration in subjects with prediabetes and type 2 diabetes mellitus: a GRADE-assessed systematic review, meta-analysis, and meta-regression of randomized clinical trials. Eur J Nutr. https://doi.org/10.1007/s00394-022-03012-9
doi: 10.1007/s00394-022-03012-9
Kumar H, Dhalaria R, Guleria S, et al (2023) Anti-oxidant potential of plants and probiotic spp. in alleviating oxidative stress induced by H2O2. Biomedicine & Pharmacotherapy 165:115022. https://doi.org/10.1016/j.biopha.2023.115022
AL-Ishaq RK, Samuel SM, Büsselberg D (2023) The influence of gut microbial species on diabetes mellitus. Int J Mol Sci 24:8118. https://doi.org/10.3390/ijms24098118
doi: 10.3390/ijms24098118
Sharma S, Tripathi P (2019) Gut microbiome and type 2 diabetes: where we are and where to go? J Nutr Biochem 63:101
doi: 10.1016/j.jnutbio.2018.10.003
Wu J, Yang K, Fan H, et al (2023) Targeting the gut microbiota and its metabolites for type 2 diabetes mellitus. Front Endocrinol (Lausanne) 14. https://doi.org/10.3389/fendo.2023.1114424
Ďásková N, Modos I, Krbcová M, et al (2023) Multi-omics signatures in new-onset diabetes predict metabolic response to dietary inulin: findings from an observational study followed by an interventional trial. Nutr Diabetes 13. https://doi.org/10.1038/s41387-023-00235-5
Jiang L, Zhang J, Fang M, et al (2022) Analysis of subgingival micro-organisms based on multi-omics and Treg/Th17 balance in type 2 diabetes with/without periodontitis. Front Microbiol 13. https://doi.org/10.3389/fmicb.2022.939608
Zhu Q, Qi N, Shen L, et al (2023) Sexual dimorphism in lipid metabolism and gut microbiota in mice fed a high-fat diet. Nutrients 15. https://doi.org/10.3390/nu15092175
Fernández-Edreira D, Liñares-Blanco J, Fernandez-Lozano C (2020) Identification of Prevotella, Anaerotruncus and Eubacterium genera by machine learning analysis of metagenomic profiles for stratification of patients affected by type i diabetes. https://doi.org/10.3390/proceedings2020054050
Smith BJ, Miller RA, Schmidt TM (2021) Muribaculaceae genomes assembled from metagenomes suggest genetic drivers of differential response to acarbose treatment in mice. mSphere 6. https://doi.org/10.1128/msphere.00851-21
Zhao J, Wang L, Cheng S, et al (2022) a potential synbiotic strategy for the prevention of type 2 diabetes: Lactobacillus paracasei JY062 and Exopolysaccharide Isolated from Lactobacillus plantarum JY039. Nutrients 14. https://doi.org/10.3390/nu14020377
Matsumoto Y, Ishii M, Hasegawa S, Sekimizu K (2019) Enterococcus faecalis YM0831 suppresses sucrose-induced hyperglycemia in a silkworm model and in humans. Commun Biol 2. https://doi.org/10.1038/s42003-019-0407-5
Chen Z, Radjabzadeh D, Chen L, et al (2021) Association of insulin resistance and type 2 diabetes with gut microbial diversity: a microbiome-wide analysis from population studies. JAMA Netw Open 4. https://doi.org/10.1001/jamanetworkopen.2021.18811
Karlsson FH, Tremaroli V, Nookaew I, et al (2013) Gut metagenome in European women with normal, impaired and diabetic glucose control. Nature 498. https://doi.org/10.1038/nature12198
Zhang X, Shen D, Fang Z, et al (2013) Human gut microbiota changes reveal the progression of glucose intolerance. PLoS One 8. https://doi.org/10.1371/journal.pone.0071108